nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Phentermine—obesity	0.226	0.529	CrCtD
Tolazoline—Methamphetamine—obesity	0.202	0.471	CrCtD
Tolazoline—HRH2—Cimetidine—obesity	0.0448	0.197	CbGbCtD
Tolazoline—ADRA1A—Phendimetrazine—obesity	0.028	0.123	CbGbCtD
Tolazoline—ADRA2C—Methamphetamine—obesity	0.0268	0.118	CbGbCtD
Tolazoline—ADRA2B—Methamphetamine—obesity	0.0254	0.112	CbGbCtD
Tolazoline—ADRA2A—Benzphetamine—obesity	0.0221	0.0973	CbGbCtD
Tolazoline—ADRA1A—Benzphetamine—obesity	0.0212	0.0933	CbGbCtD
Tolazoline—ADRA2A—Phenylpropanolamine—obesity	0.0211	0.0928	CbGbCtD
Tolazoline—ADRA1A—Phenylpropanolamine—obesity	0.0202	0.089	CbGbCtD
Tolazoline—ADRA2A—Methamphetamine—obesity	0.0177	0.0778	CbGbCtD
Tolazoline—Phenol—Phenylpropanolamine—obesity	0.0116	0.039	CrCrCtD
Tolazoline—Phenelzine—Phenylpropanolamine—obesity	0.0112	0.0374	CrCrCtD
Tolazoline—Phentermine—Phenylpropanolamine—obesity	0.0107	0.036	CrCrCtD
Tolazoline—Pargyline—Phentermine—obesity	0.0103	0.0346	CrCrCtD
Tolazoline—Benzyl alcohol—Phenylpropanolamine—obesity	0.00997	0.0334	CrCrCtD
Tolazoline—Phenol—Phentermine—obesity	0.00988	0.0331	CrCrCtD
Tolazoline—Mephentermine—Phentermine—obesity	0.00988	0.0331	CrCrCtD
Tolazoline—Phenelzine—Phentermine—obesity	0.00948	0.0318	CrCrCtD
Tolazoline—Pargyline—Methamphetamine—obesity	0.0092	0.0308	CrCrCtD
Tolazoline—Dextroamphetamine—Diethylpropion—obesity	0.00904	0.0303	CrCrCtD
Tolazoline—Amphetamine—Diethylpropion—obesity	0.00904	0.0303	CrCrCtD
Tolazoline—Phenol—Methamphetamine—obesity	0.00881	0.0295	CrCrCtD
Tolazoline—Mephentermine—Methamphetamine—obesity	0.00881	0.0295	CrCrCtD
Tolazoline—Methamphetamine—Diethylpropion—obesity	0.00878	0.0294	CrCrCtD
Tolazoline—Dextroamphetamine—Phenylpropanolamine—obesity	0.00877	0.0294	CrCrCtD
Tolazoline—Amphetamine—Phenylpropanolamine—obesity	0.00877	0.0294	CrCrCtD
Tolazoline—Methamphetamine—Phenylpropanolamine—obesity	0.00852	0.0286	CrCrCtD
Tolazoline—Benzyl alcohol—Phentermine—obesity	0.00848	0.0284	CrCrCtD
Tolazoline—Phenelzine—Methamphetamine—obesity	0.00845	0.0283	CrCrCtD
Tolazoline—Phentermine—Methamphetamine—obesity	0.00813	0.0273	CrCrCtD
Tolazoline—Phenacemide—Phentermine—obesity	0.00769	0.0258	CrCrCtD
Tolazoline—Benzyl alcohol—Methamphetamine—obesity	0.00756	0.0253	CrCrCtD
Tolazoline—Dextroamphetamine—Phentermine—obesity	0.00746	0.025	CrCrCtD
Tolazoline—Amphetamine—Phentermine—obesity	0.00746	0.025	CrCrCtD
Tolazoline—Pargyline—Benzphetamine—obesity	0.00729	0.0244	CrCrCtD
Tolazoline—Methamphetamine—Phentermine—obesity	0.00725	0.0243	CrCrCtD
Tolazoline—L-Phenylalanine—Diethylpropion—obesity	0.00688	0.023	CrCrCtD
Tolazoline—Phenacemide—Methamphetamine—obesity	0.00685	0.023	CrCrCtD
Tolazoline—L-Phenylalanine—Phenylpropanolamine—obesity	0.00667	0.0224	CrCrCtD
Tolazoline—Dextroamphetamine—Methamphetamine—obesity	0.00665	0.0223	CrCrCtD
Tolazoline—Amphetamine—Methamphetamine—obesity	0.00665	0.0223	CrCrCtD
Tolazoline—Antazoline—Benzphetamine—obesity	0.00579	0.0194	CrCrCtD
Tolazoline—L-Phenylalanine—Phentermine—obesity	0.00568	0.019	CrCrCtD
Tolazoline—Amphetamine—Benzphetamine—obesity	0.00527	0.0177	CrCrCtD
Tolazoline—Dextroamphetamine—Benzphetamine—obesity	0.00527	0.0177	CrCrCtD
Tolazoline—Methamphetamine—Benzphetamine—obesity	0.00512	0.0172	CrCrCtD
Tolazoline—L-Phenylalanine—Methamphetamine—obesity	0.00506	0.017	CrCrCtD
Tolazoline—Phenelzine—GPT—obesity	0.000453	0.331	CrCbGaD
Tolazoline—Amphetamine—CARTPT—obesity	0.000363	0.266	CrCbGaD
Tolazoline—Phenelzine—AOC3—obesity	0.000292	0.213	CrCbGaD
Tolazoline—ADRA1A—hindbrain—obesity	0.000162	0.0849	CbGeAlD
Tolazoline—HRH2—cardiovascular system—obesity	0.000154	0.0809	CbGeAlD
Tolazoline—HRH2—digestive system—obesity	0.000128	0.0672	CbGeAlD
Tolazoline—HRH2—adrenal gland—obesity	0.000122	0.064	CbGeAlD
Tolazoline—HRH2—endocrine gland—obesity	0.000106	0.0555	CbGeAlD
Tolazoline—HRH2—liver—obesity	9.54e-05	0.0501	CbGeAlD
Tolazoline—ADRA2A—islet of Langerhans—obesity	7.95e-05	0.0417	CbGeAlD
Tolazoline—ADRA2C—adrenal cortex—obesity	7.9e-05	0.0414	CbGeAlD
Tolazoline—HRH1—respiratory system—obesity	7.64e-05	0.0401	CbGeAlD
Tolazoline—ADRA1A—cardiovascular system—obesity	7.56e-05	0.0397	CbGeAlD
Tolazoline—ADRA1A—adipose tissue—obesity	6.67e-05	0.035	CbGeAlD
Tolazoline—ADRA2C—pituitary gland—obesity	6.38e-05	0.0335	CbGeAlD
Tolazoline—ADRA2C—adipose tissue—obesity	6.35e-05	0.0334	CbGeAlD
Tolazoline—ADRA1A—adrenal gland—obesity	5.98e-05	0.0314	CbGeAlD
Tolazoline—ADRA2C—adrenal gland—obesity	5.7e-05	0.0299	CbGeAlD
Tolazoline—Phentermine—SLC6A4—obesity	5.25e-05	0.0384	CrCbGaD
Tolazoline—ADRA1A—endocrine gland—obesity	5.19e-05	0.0272	CbGeAlD
Tolazoline—HRH1—adipose tissue—obesity	5.16e-05	0.0271	CbGeAlD
Tolazoline—ADRA2A—pituitary gland—obesity	5.09e-05	0.0267	CbGeAlD
Tolazoline—ADRA2A—adipose tissue—obesity	5.07e-05	0.0266	CbGeAlD
Tolazoline—HRH1—digestive system—obesity	4.86e-05	0.0255	CbGeAlD
Tolazoline—Benzyl alcohol—CYP2E1—obesity	4.84e-05	0.0354	CrCbGaD
Tolazoline—ADRA1A—liver—obesity	4.68e-05	0.0245	CbGeAlD
Tolazoline—HRH1—adrenal gland—obesity	4.63e-05	0.0243	CbGeAlD
Tolazoline—ADRA2A—adrenal gland—obesity	4.55e-05	0.0239	CbGeAlD
Tolazoline—ADRA2C—liver—obesity	4.46e-05	0.0234	CbGeAlD
Tolazoline—Phenelzine—CYP2E1—obesity	4.09e-05	0.03	CrCbGaD
Tolazoline—Amphetamine—SLC6A4—obesity	4.04e-05	0.0295	CrCbGaD
Tolazoline—HRH1—endocrine gland—obesity	4.02e-05	0.0211	CbGeAlD
Tolazoline—Amphetamine—DRD2—obesity	4.01e-05	0.0294	CrCbGaD
Tolazoline—ADRA2A—endocrine gland—obesity	3.94e-05	0.0207	CbGeAlD
Tolazoline—Methamphetamine—SLC6A4—obesity	3.74e-05	0.0274	CrCbGaD
Tolazoline—HRH1—Signaling Pathways—FOXO1—obesity	1.73e-06	3.99e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RPS6KB1—obesity	1.72e-06	3.98e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—TYK2—obesity	1.72e-06	3.97e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CB—obesity	1.71e-06	3.96e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF2—obesity	1.71e-06	3.95e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MTHFR—obesity	1.71e-06	3.94e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LPL—obesity	1.71e-06	3.94e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CB—obesity	1.71e-06	3.94e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PPARG—obesity	1.7e-06	3.94e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—RHOA—obesity	1.7e-06	3.93e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GNAS—obesity	1.7e-06	3.92e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—FOXO1—obesity	1.69e-06	3.91e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RPS6KB1—obesity	1.69e-06	3.91e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3R1—obesity	1.69e-06	3.89e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—POMC—obesity	1.68e-06	3.88e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARA—obesity	1.67e-06	3.87e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CB—obesity	1.67e-06	3.87e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ESR1—obesity	1.67e-06	3.86e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IRS2—obesity	1.67e-06	3.86e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—INS—obesity	1.67e-06	3.86e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AGT—obesity	1.67e-06	3.86e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—AKT1—obesity	1.66e-06	3.84e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOB—obesity	1.66e-06	3.84e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—PIK3CA—obesity	1.65e-06	3.82e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PRKCB—obesity	1.65e-06	3.82e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—F2—obesity	1.65e-06	3.82e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOE—obesity	1.64e-06	3.78e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—LEP—obesity	1.64e-06	3.78e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—BAD—obesity	1.63e-06	3.77e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AGT—obesity	1.62e-06	3.75e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL5—obesity	1.62e-06	3.75e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CAV1—obesity	1.62e-06	3.75e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOA1—obesity	1.62e-06	3.74e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKCD—obesity	1.6e-06	3.7e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—STAT3—obesity	1.59e-06	3.68e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOE—obesity	1.59e-06	3.67e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LPL—obesity	1.59e-06	3.66e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CG—obesity	1.58e-06	3.65e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CAV1—obesity	1.57e-06	3.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—FOXO1—obesity	1.57e-06	3.64e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKCD—obesity	1.57e-06	3.63e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RPS6KB1—obesity	1.57e-06	3.63e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOA1—obesity	1.57e-06	3.63e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—HTR2A—obesity	1.57e-06	3.62e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—C3—obesity	1.57e-06	3.62e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IRS1—obesity	1.56e-06	3.61e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ESR1—obesity	1.56e-06	3.61e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CB—obesity	1.56e-06	3.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CD—obesity	1.55e-06	3.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—F2—obesity	1.54e-06	3.57e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PRKCB—obesity	1.54e-06	3.57e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—HTR2A—obesity	1.54e-06	3.55e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—C3—obesity	1.54e-06	3.55e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—obesity	1.53e-06	3.54e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—BAD—obesity	1.52e-06	3.52e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—POMC—obesity	1.5e-06	3.48e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INS—obesity	1.5e-06	3.46e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IRS2—obesity	1.49e-06	3.44e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGT—obesity	1.49e-06	3.44e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MYC—obesity	1.48e-06	3.42e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CG—obesity	1.48e-06	3.41e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFB1—obesity	1.48e-06	3.41e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL2—obesity	1.47e-06	3.4e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3R1—obesity	1.47e-06	3.39e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NOS3—obesity	1.47e-06	3.39e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IRS2—obesity	1.46e-06	3.38e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCD—obesity	1.46e-06	3.38e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGT—obesity	1.46e-06	3.37e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IRS1—obesity	1.46e-06	3.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LEP—obesity	1.46e-06	3.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOE—obesity	1.46e-06	3.37e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF1—obesity	1.45e-06	3.34e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT2—obesity	1.45e-06	3.34e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CAV1—obesity	1.44e-06	3.34e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOA1—obesity	1.44e-06	3.33e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CG—obesity	1.43e-06	3.31e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOE—obesity	1.43e-06	3.3e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LEP—obesity	1.43e-06	3.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—HTR2A—obesity	1.43e-06	3.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—C3—obesity	1.43e-06	3.3e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CAV1—obesity	1.42e-06	3.27e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOA1—obesity	1.41e-06	3.27e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—POMC—obesity	1.41e-06	3.25e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INS—obesity	1.4e-06	3.23e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ESR1—obesity	1.39e-06	3.22e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CD—obesity	1.39e-06	3.21e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARG—obesity	1.38e-06	3.2e-05	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PIK3CA—obesity	1.38e-06	3.18e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL2—obesity	1.38e-06	3.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—F2—obesity	1.37e-06	3.18e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKCB—obesity	1.37e-06	3.18e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SERPINE1—obesity	1.37e-06	3.18e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ESR1—obesity	1.37e-06	3.16e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—POMC—obesity	1.37e-06	3.15e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—BAD—obesity	1.36e-06	3.14e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IRS2—obesity	1.36e-06	3.14e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—INS—obesity	1.36e-06	3.14e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGT—obesity	1.36e-06	3.13e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CB—obesity	1.35e-06	3.13e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF1—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT2—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKCB—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—F2—obesity	1.35e-06	3.12e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—obesity	1.34e-06	3.1e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TYK2—obesity	1.34e-06	3.09e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—BAD—obesity	1.33e-06	3.08e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LEP—obesity	1.33e-06	3.07e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOE—obesity	1.33e-06	3.07e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RHOA—obesity	1.33e-06	3.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CAV1—obesity	1.32e-06	3.04e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CG—obesity	1.32e-06	3.04e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOA1—obesity	1.31e-06	3.04e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3R1—obesity	1.31e-06	3.03e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOS3—obesity	1.31e-06	3.03e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IRS1—obesity	1.3e-06	3e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CD—obesity	1.3e-06	3e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CG—obesity	1.29e-06	2.98e-05	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	1.29e-06	2.97e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SERPINE1—obesity	1.28e-06	2.97e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IRS1—obesity	1.28e-06	2.95e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ESR1—obesity	1.27e-06	2.93e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CD—obesity	1.26e-06	2.91e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PIK3CA—obesity	1.26e-06	2.9e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—F2—obesity	1.25e-06	2.9e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCB—obesity	1.25e-06	2.9e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—POMC—obesity	1.25e-06	2.89e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PIK3CA—obesity	1.25e-06	2.89e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TYK2—obesity	1.25e-06	2.89e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INS—obesity	1.25e-06	2.88e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—obesity	1.24e-06	2.88e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RHOA—obesity	1.24e-06	2.86e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—BAD—obesity	1.24e-06	2.86e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—POMC—obesity	1.23e-06	2.84e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3R1—obesity	1.23e-06	2.83e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOS3—obesity	1.23e-06	2.83e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL2—obesity	1.23e-06	2.83e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INS—obesity	1.22e-06	2.82e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MTOR—obesity	1.21e-06	2.8e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CB—obesity	1.21e-06	2.8e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF1—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT2—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL2—obesity	1.2e-06	2.78e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.2e-06	2.77e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NOS3—obesity	1.19e-06	2.75e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3R1—obesity	1.19e-06	2.75e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IRS1—obesity	1.19e-06	2.74e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF1—obesity	1.18e-06	2.73e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT2—obesity	1.18e-06	2.73e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PIK3CA—obesity	1.17e-06	2.7e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CD—obesity	1.16e-06	2.67e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PIK3CA—obesity	1.15e-06	2.65e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SERPINE1—obesity	1.14e-06	2.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—POMC—obesity	1.14e-06	2.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INS—obesity	1.14e-06	2.62e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CD—obesity	1.13e-06	2.62e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MTOR—obesity	1.13e-06	2.61e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CB—obesity	1.13e-06	2.61e-05	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.12e-06	2.6e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.12e-06	2.6e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.12e-06	2.59e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL2—obesity	1.12e-06	2.58e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TYK2—obesity	1.11e-06	2.57e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—obesity	1.11e-06	2.57e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—obesity	1.11e-06	2.56e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RHOA—obesity	1.1e-06	2.55e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CB—obesity	1.1e-06	2.54e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF1—obesity	1.1e-06	2.54e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT2—obesity	1.1e-06	2.54e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3R1—obesity	1.09e-06	2.52e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOS3—obesity	1.09e-06	2.52e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TYK2—obesity	1.09e-06	2.52e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—obesity	1.09e-06	2.52e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RHOA—obesity	1.08e-06	2.5e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOS3—obesity	1.07e-06	2.48e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3R1—obesity	1.07e-06	2.48e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.05e-06	2.44e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—obesity	1.05e-06	2.43e-05	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—obesity	1.05e-06	2.43e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.04e-06	2.41e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.04e-06	2.41e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PIK3CA—obesity	1.04e-06	2.4e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—obesity	1.03e-06	2.39e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—obesity	1.03e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAPK8—obesity	1.02e-06	2.37e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—obesity	1.02e-06	2.36e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PIK3CA—obesity	1.02e-06	2.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TYK2—obesity	1.01e-06	2.34e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CB—obesity	1.01e-06	2.33e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MTOR—obesity	1.01e-06	2.33e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RHOA—obesity	1.01e-06	2.32e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOS3—obesity	9.96e-07	2.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3R1—obesity	9.96e-07	2.3e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MTOR—obesity	9.89e-07	2.29e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CB—obesity	9.89e-07	2.29e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—obesity	9.83e-07	2.27e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAPK8—obesity	9.56e-07	2.21e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—obesity	9.54e-07	2.2e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CA—obesity	9.48e-07	2.19e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—obesity	9.36e-07	2.16e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—obesity	9.36e-07	2.16e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—obesity	9.21e-07	2.13e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CB—obesity	9.19e-07	2.12e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MTOR—obesity	9.19e-07	2.12e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—obesity	9.18e-07	2.12e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—obesity	9.04e-07	2.09e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—obesity	8.76e-07	2.02e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—obesity	8.74e-07	2.02e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MYC—obesity	8.7e-07	2.01e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFB1—obesity	8.68e-07	2e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—obesity	8.6e-07	1.99e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—obesity	8.53e-07	1.97e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAPK8—obesity	8.52e-07	1.97e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—obesity	8.5e-07	1.96e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—obesity	8.4e-07	1.94e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAPK8—obesity	8.36e-07	1.93e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—obesity	8.34e-07	1.93e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CA—obesity	8.25e-07	1.91e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MYC—obesity	8.13e-07	1.88e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFB1—obesity	8.11e-07	1.87e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—obesity	7.99e-07	1.85e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—obesity	7.79e-07	1.8e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAPK8—obesity	7.77e-07	1.79e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—obesity	7.75e-07	1.79e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—obesity	7.64e-07	1.77e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CA—obesity	7.38e-07	1.71e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MYC—obesity	7.24e-07	1.67e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFB1—obesity	7.22e-07	1.67e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MYC—obesity	7.1e-07	1.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—obesity	7.1e-07	1.64e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFB1—obesity	7.09e-07	1.64e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CA—obesity	6.9e-07	1.59e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—obesity	6.74e-07	1.56e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CA—obesity	6.7e-07	1.55e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MYC—obesity	6.6e-07	1.52e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFB1—obesity	6.58e-07	1.52e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—obesity	6.54e-07	1.51e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CA—obesity	6.14e-07	1.42e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—obesity	6.11e-07	1.41e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—obesity	6.03e-07	1.39e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CA—obesity	6.03e-07	1.39e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—obesity	5.63e-07	1.3e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CA—obesity	5.6e-07	1.29e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—obesity	5.47e-07	1.26e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—obesity	5.44e-07	1.26e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—obesity	5.34e-07	1.23e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—obesity	5.02e-07	1.16e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—obesity	4.96e-07	1.15e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—obesity	4.93e-07	1.14e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—obesity	4.58e-07	1.06e-05	CbGpPWpGaD
